412
Y.-C. Wu et al. / Journal of Fluorine Chemistry 127 (2006) 409–416
FTIR (KBr): y 1782 (CO), 1723 (CO), 1582, 1479, 1371,
1298, 1231, 1158, 1124, 1100, 1042, 955, 824, 736 cmÀ1
Anal. calcd. for C15H9F6N5O3: C, 42.77; H, 2.15; N, 16.63.
Found: C, 42.65; H, 2.11; N, 16.45.
.
1H NMR (200 MHz, CDCl3): d 1.44 (3H, t, J = 7.16 Hz,
CH2-CH3), 4.49 (2H, q, J = 7.14 Hz, CH2-CH3), 7.50–7.67
(3H, m, Ar-H).
13C NMR (75 MHz, CDCl3): d 158.15 (s, CO), 147.84 (q,
2JCF = 40.05 Hz, C-7), 145.25 (s, CO), 138.24, 138.01,
133.34, 132.20, 130.86, 130.23, 128.70, 119.24 (q,
1JCF = 270.60 Hz, CF3), 109.93, 62.72 (s, CH2-CH3),
13.95 (s, CH2-CH3).
MS (TOF EI): m/z 376 (M+-OEt)(4%), 329(1%), 289 (2%),
269 (4%), 260 (3%), 208 (10%), 187 (100%), 180 (20%),
161 (54%), 124 (34%), 97 (4%), 73 (5%), 61 (2%).
Anal. calcd. for C14H8Cl2F3N5O3: C, 39.83; H, 1.91; N,
16.59. Found: C, 39.74; H, 2.00; N, 16.42.
2.5.7. Ethyl 7-(trifluoromethyl)-3,4-dihydro-3-(2-
nitrophenyl)-4-oxopyrazolo[5,1-d][1,2,3,5]tetrazine-8-
carboxylate (8g)
Yellow solid; yield: 85.4%; mp = 144–145 8C.
FTIR (KBr): y 3494, 3354, 3240, 1746 (CO), 1712 (CO),
1614, 1504, 1441, 1344, 1217, 1166, 750 cmÀ1
.
1H NMR (300 MHz, CDCl3): d 1.36 (3H, t, J = 7.12 Hz,
CH2-CH3), 4.33 (2H, q, J = 7.12 Hz, CH2-CH3), 7.30 (1H,
dd, J = 1.09, 7.89 Hz, Ar-H), 7.30 (1H, dd, J = 1.09,
7.89 Hz, Ar-H), 7.73 (1H, td, J = 1.30, 7.90 Hz, Ar-H),
8.30 (1H, dd, J = 1.38, 8.44 Hz, Ar-H), 8.64 (1H, d,
J = 8.47 Hz, Ar-H).
13C NMR (75 MHz, CDCl3): d 162.69 (s, CO), 154.55,
2
149.21 (s, CO), 143.84 (q, JCF = 40.05 Hz, C-7), 137.34,
2.5.5. Ethyl 7-(trifluoromethyl)-3-(2-fluorophenyl)-3,4-
dihydro-4-oxopyrazolo[5,1-d][1,2,3,5]tetrazine-8-
carboxylate (8e)
135.84, 132.80, 126.20, 124.39, 121.45, 119.24 (q,
1JCF = 270.00 Hz, CF3), 92.36, 62.66 (s, CH2-CH3), 13.98
(s, CH2-CH3).
Orange solid; yield: 71.6%; mp = 117–118 8C.
FTIR (KBr): y 1772 (CO), 1727 (CO), 1306, 1242, 1224,
MS (TOF EI): m/z 342 (2%), 223(53%), 177 (100%), 164
(20%), 158 (11%), 120 (15%), 106 (5%), 90 (19%), 63 (4%),
52 (2%).
1190, 1154, 1099 cmÀ1
.
1H NMR (300 MHz, CDCl3): d 1.46 (3H, t, J = 7.14 Hz,
CH2-CH3), 4.54 (2H, q, J = 7.14 Hz, CH2-CH3), 7.38 (1H, t,
J = 8.54 Hz, Ar-H), 7.40 (1H, t, J = 7.92 Hz, Ar-H), 7.58–
7.67 (2H, m, Ar-H).
Anal. calcd. for C14H9F3N6O5: C, 42.22; H, 2.28; N, 21.10.
Found: C, 42.19; H, 2.27; N, 20.95.
13C NMR (75 MHz, CDCl3): d 158.46 (s, CO), 157.34 (d,
2.5.8. Ethyl 7-(trifluoromethyl)-3,4-dihydro-3-(4-
nitrophenyl)-4-oxopyrazolo[5,1-d][1,2,3,5]tetrazine-8-
carboxylate (8h)
3
1JCF = 250.50 Hz), 155.39 (d, JCF = 9.75 Hz), 147.87 (q,
2JCF = 40.06 Hz, C-7), 145.30 (s, CO), 137.98, 133.04 (d,
2
3JCF = 8.25 Hz), 128.81 (d, JCF = 39.75 Hz), 125.28 (d,
Yellow solid; yield: 92.3%; mp = 139–140 8C.
FTIR (KBr): y 1740 (CO), 1716 (CO), 1578, 1497, 1332,
4JCF = 3.75 Hz), 119.23 (q, 1JCF = 270.00 Hz, CF3), 117.26
(d, 2JCF = 18.75 Hz), 109.33, 63.09 (s, CH2-CH3), 14.07 (s,
CH2-CH3).
1302, 1231, 1203, 1159, 1110, 1010, 850 cmÀ1
.
1H NMR (200 MHz, d6-Me2SO): d 1.44 (3H, t, J = 7.06 Hz,
CH2-CH3), 4.53 (2H, q, J = 7.06 Hz, CH2-CH3), 7.51–7.67
(4H, m, Ar-H).
MS (TOF EI): m/z 371 (M+) (2%), 326 (2%), 208 (3%), 180
(8%), 163 (14%), 137 (100%), 109 (27%), 89 (6%), 82 (8%),
62 (2%), 57 (2%).
13C NMR (75 MHz, d6-Me2SO):
d
158.43 (q,
Anal. calcd. for C14H9F4N5O3: C, 45.29; H, 2.44; N, 18.86.
Found: C, 45.33; H, 2.58; N, 18.74.
2JCF = 34.95 Hz, C-7), 147.26 (s, CO), 142.01 (s, CO),
137.85 (q, 1JCF = 270.60 Hz, CF3), 128.12, 126.83, 125.59,
3
125.38, 118.39 (d, JCF = 5.85 Hz, C-8), 112.79, 62.72 (d,
JCF = 6.98 Hz, CH2-CH3), 13.95 (d, JCF = 21.90 Hz, CH3).
2.5.6. Ethyl 7-(trifluoromethyl)-3-(2-
(trifluoromethyl)phenyl)-3,4-dihydro-4-oxopyrazolo[5,1-
d][1,2,3,5]tetrazine-8-carboxylate (8f)
MS (TOF EI): m/z 344 (2%), 302(3%), 223 (1%), 177 (3%),
164 (100%), 138 (79%), 134 (45%), 122 (5%), 118 (12%),
108 (32%), 90 (47%), 65 (25%), 63 (12%).
Orange solid; yield: 96.8%; mp = 122–123 8C.
FTIR (KBr): y 3457, 3345, 2232, 1734 (CO), 1689 (CO),
Anal. calcd. for C14H9F3N6O5: C, 42.22; H, 2.28; N, 21.10.
Found: C, 42.14; H, 2.35; N, 21.14.
1620, 1545, 1459, 1326, 1288, 1237, 1142, 1036, 764 cmÀ1
.
1H NMR (300 MHz, CDCl3): d 1.45 (3H, t, J = 7.14 Hz,
CH2-CH3), 4.47 (2H, q, J = 7.14 Hz, CH2-CH3), 7.23–8.20
(4H, m, Ar-H).
2.5.9. Ethyl 3-(4-(ethoxycarbonyl)phenyl)-7-
(trifluoromethyl)-3,4-dihydro-4-oxopyrazolo[5,1-
d][1,2,3,5]tetrazine-8-carboxylate (8i)
13C NMR (75 MHz, CDCl3): d 162.63 (s, CO), 158.65,
3
154.37, 149.14 (s, CO), 132.95 (q, JCF = 10.50 Hz),
White solid; yield: 94.1%; mp = 58–59 8C.
FTIR (KBr): y 3438, 2989, 1780 (CO), 1730 (CO), 1705
(CO), 1575, 1477, 1371, 1296, 1223, 1166, 1116, 1044, 771,
697 cmÀ1
.
1H NMR (300 MHz, CDCl3): d 1.40–1.47 (6H, m, 2 CH2-
CH3), 4.42 (2H, q, J = 7.13 Hz, CH2-CH3), 4.51 (2H, q,
J = 7.13 Hz, CH2-CH3), 7.76 (2H, d, J = 8.71 Hz, Ar-H),
8.26 (2H, d, J = 8.68 Hz, Ar-H).
2
3
126.58(q, JCF = 15.75 Hz), 126.52 (q, JCF = 5.25 Hz),
2
125.41 (q, JCF = 18.83 Hz), 130.23, 123.68, 119.81 (q,
1JCF = 268.88 Hz, CF3), 118.53 (q, 1JCF = 268.13 Hz, CF3),
117.63, 62.77 (s, CH2-CH3), 13.71 (s, CH2-CH3).
MS (TOF EI): m/z 333 (12%), 305 (13%), 285 (2%), 266
(2%), 216 (8%), 187 (41%), 173 (38%), 145 (100%), 141
(11%), 114 (11%), 95 (6%), 75 (2%), 63 (1%).